Last reviewed · How we verify
NCT04607330
Protein Top-up Acceptability Study for Patients With Increased Protein Needs
NA trial testing High protein liquid in Cancer in 18 participants. Completed in 28 June 2022.
30 May 2022
Quick facts
| Lead sponsor | Nutricia UK Ltd |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | other |
| Enrollment | 18 |
| Start date | 28 October 2020 |
| Primary completion | 30 May 2022 |
| Estimated completion | 28 June 2022 |
| Sites | 2 locations across United Kingdom |
Drugs / interventions tested
- High protein liquid
Conditions studied
- Cancer — all drugs for Cancer →
- Neurological Injury — all drugs for Neurological Injury →
- Respiratory Disease — all drugs for Respiratory Disease →
- Stroke — all drugs for Stroke →
Sponsor
Nutricia UK Ltd
Who can join
Adults 18 to 100, any sex, with Cancer or Neurological Injury. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this prospective, single-arm intervention study is to evaluate the acceptability (compliance, gastrointestinal tolerance, and palatability) to a low calorie, low volume, ready to use, high protein liquid in patients with elevated protein needs.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04607330
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cancer
Currently open trials in the same condition.
- NCT07390045 — Exercise and Cognitive Rehabilitation Interventions for Older Cancer Survivors · NA · recruiting
- NCT07528547 — Hypersight and Ethos In Pediatric Radiotherapy · NA · recruiting
- NCT07481890 — Feasibility and Efficacy of the EMDR Toolbox Method in Cancer Patients. · NA · recruiting
- NCT07402057 — Implementation and Evaluation of a Program Aimed at Facilitating Palliative Care Conversations · NA · recruiting
- NCT07305740 — On-Trac: An Online Intervention for Cancer Survivors Managing Anxiety · NA · recruiting
Other Nutricia UK Ltd trials
Trials by the same sponsor.
- NCT06941532 — GMP Powdered Substitutes in PKU and TYR · NA · recruiting
- NCT04272736 — PKU Low Calorie Drink Study · NA · withdrawn
- NCT05822557 — Bolus Pouch Feed Study · NA · completed
- NCT05411848 — 2kcal Tube Feed Study · NA · completed
- NCT05269992 — Childrens Real Food Tolerance Study · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04607330 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Nutricia UK Ltd
- Last refreshed: 20 April 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04607330.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing